APA

Conroy G., Salleron J., Belle A., Bensenane M., Nani A., Ayav A., Peiffert D., Lopez A., Baumann C., Barraud H. & Bronowicki J. (2017). The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib. : Oncotarget.

Chicago

Conroy Guillaume, Salleron Julia, Belle Arthur, Bensenane Mouni, Nani Abdelbasset, Ayav Ahmet, Peiffert Didier, Lopez Anthony, Baumann Cédric, Barraud Hélène and Bronowicki Jean-Pierre. 2017. The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib. : Oncotarget.

Harvard

Conroy G., Salleron J., Belle A., Bensenane M., Nani A., Ayav A., Peiffert D., Lopez A., Baumann C., Barraud H. and Bronowicki J. (2017). The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib. : Oncotarget.

MLA

Conroy Guillaume, Salleron Julia, Belle Arthur, Bensenane Mouni, Nani Abdelbasset, Ayav Ahmet, Peiffert Didier, Lopez Anthony, Baumann Cédric, Barraud Hélène and Bronowicki Jean-Pierre. The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib. : Oncotarget. 2017.